Table 1 A description of the 18 patient subjects completing the study
Patients (n = 18) | |
|---|---|
Gender (M:F) | 8:10 |
Age at recruitment (years) | 17.7 (1.9) |
Age of onset (years) | 13.9 (3.0) |
Polarity of index episode (%) d, D, m, M | 61, 22, 0, 17 |
Duration of illness (years) | 3.4 (2.7) |
Most recent mood episode (%) D, m, M | 33, 45, 22 |
Bipolar Diagnosis (%) | |
BPI | 22 |
BPII | 11 |
BPNOS | 67 |
Lifetime Psychotic Features (%) | 61 |
Hospitalization Ever (%) | 44 |
Clinical Course (%) | |
Episodic | 11 |
Non-Episodic | 89 |
Comorbid Disorders (%) | |
Anxiety | 33 |
ADHD | 22 |
Sleep | 17 |
None | 22 |
Mean quetiapine dose over the study (SD) | 340.9 mg (276.5) |
Mean quetiapine dose at study end (SD) | 294.6 mg (267.3) |